Results 221 to 230 of about 82,795 (269)

Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study

The Clinical Respiratory Journal, Volume 20, Issue 5, May 2026.
This study preliminarily concludes that the extent of destroyed lung, whether preoperative CTA, technical factors, and the progression of underlying diseases are independent risk factors associated with hemoptysis recurrence after bronchial artery embolization (BAE). Through comprehensive preoperative assessments, individualized embolization strategies,
Tianhua Yue, Ling Li, Zhengyu Yue
wiley   +1 more source

Erratum to " The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment" [Turkish Journal of Medical Sciences 55 (4): 877-886]. [PDF]

Turk J Med Sci
Uyanik SA, Birgi E, Öztürk S, Asfuroğlu U, Tangobay E, Güven HE.   +5 more
europepmc   +1 more source

Identification of Urinary Exosomal microRNAs Associated With Subclinical Acute T‐Cell‐Mediated Rejection in Kidney Transplant Recipients

Clinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT This study aimed to evaluate the diagnostic utility of urinary exosomal microRNAs (miRNAs) in subclinical rejection following kidney transplantation by comparing miRNA expression profiles in urinary exosomes between patients with no evidence of rejection and patients with subclinical T‐cell‐mediated rejection (sc‐TCMR), as confirmed by ...
Soichiro Tajima, Miori Ono, Yuto Kawazoe, Hiroshi Noguchi, Tomohiro Shigematsu, Takashi Ogino, Shoji Nakamura, Takahiro Nakamura, Keizo Kaku, Takeshi Hirota, Ichiro Ieiri, Mayako Uchida   +11 more
wiley   +1 more source

Incidence and risk factors for contrast-induced nephropathy after angioplasty: an observational retrospective study. [PDF]

J Vasc Bras
Peres J, Toregeani JF, Pohl AC, Vendrametto AJ, de Andrade L, Moro AB.   +5 more
europepmc   +1 more source

Real‐world treatment trajectories preceding GLP‐1 receptor agonist initiation in type 2 diabetes: A descriptive UK population‐based cohort study on adherence to national clinical guidelines

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3692-3702, May 2026.
Abstract Aims To investigate glucose‐lowering treatment trajectories preceding glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) initiation in UK primary care, while assessing alignment with contemporary UK clinical guidelines, considering calendar time, cardiovascular disease (CVD) history, and obesity status.
Franziska S. Ulrich, Morten Frost Nielsen, Nicola Napoli, Andrea M. Burden   +3 more
wiley   +1 more source

Combination of atorvastatin plus N-acetylcysteine versus atorvastatin alone to prevent contrast-induced nephropathy. [PDF]

Arch Med Sci Atheroscler Dis
Habib M.
europepmc   +1 more source

Baseline and 4‐year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3777-3787, May 2026.
Abstract Aims Prediabetes is a prevalent condition associated with increased cardiovascular and renal risk. However, the long‐term impact of haemoglobin A1c (HbA1c) within the range defined as prediabetes on kidney function remains unclear. This study aimed to evaluate the association between prediabetes and renal function (estimated glomerular ...
Aitziber Izarra, Marcelino Bermúdez‐López, José M. Valdivielso, Reinald Pamplona, Gerard Torres, Dídac Mauricio, Eva Castro‐Boqué, Elvira Fernández, Rafael Simó, Cristina Hernández, Albert Lecube, on behalf of the ILERVAS project collaborators, Eva Miquel, Marta Ortega, Ferran Barbé, Jordi de Batlle, Jessica González, Manuel Portero‐Otín, Mariona Jové, Josep Franch‐Nadal, Esmeralda Castelblanco, Pere Godoy, Montse Martinez‐ Alonso, Cristina Farràs   +23 more
wiley   +1 more source

The Impact of Insulin Resistance on the Development of Post-PCI Contrast-Induced Nephropathy in Non-Diabetic STEMI. [PDF]

Acta Cardiol Sin
Mete Yıldırım A, Bayramoglu A.
europepmc   +1 more source

Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3568-3581, May 2026.
Abstract The mineralocorticoid receptor (MR) has a multifaceted role in normal physiologic functions. However, research has uncovered the deleterious consequences of overactivation of the MR. It has been implicated in chronic kidney disease (CKD) via its strong association with glomerulosclerosis, interstitial fibrosis, proteinuria, and decline in ...
Amy K. Mottl, Kamlesh Khunti, Chantal Mathieu   +2 more
wiley   +1 more source

Personalized contrast agent dosing to prevent contrast induced nephropathy in high risk populations in Guangdong, China. [PDF]

Sci Rep
Liao M, Yang Y, Chen Y, Zhou Y, Zhou W, Zhou G, Wei B, Xu W, Li Z, Lu J, Zhang B, Guo S.   +11 more
europepmc   +1 more source